Deregulated protein kinases: friend and foe in ischemic stroke
S Appunni, D Gupta, M Rubens, V Ramamoorthy… - Molecular Neurobiology - Springer
Ischemic stroke is the third leading cause of mortality worldwide, but its medical
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …
Deregulated Protein Kinases: Friend and Foe in Ischemic Stroke.
S Appunni, D Gupta, M Rubens… - Molecular …, 2021 - europepmc.org
Ischemic stroke is the third leading cause of mortality worldwide, but its medical
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …
Deregulated Protein Kinases: Friend and Foe in Ischemic Stroke
A Sandeep, D Gupta, R Muni… - Molecular …, 2021 - search.proquest.com
Ischemic stroke is the third leading cause of mortality worldwide, but its medical
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …
Deregulated Protein Kinases: Friend and Foe in Ischemic Stroke
S Appunni, D Gupta, M Rubens… - Molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Ischemic stroke is the third leading cause of mortality worldwide, but its medical
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …